Edwards Lifesciences Corporation EW
86.29
0.56
0.65%
as of 25 Sep
- Market cap
- $49.4B
- P/E
- 49.6×
Follow EW
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
46.33 | 10.61 | 32.71 | 30.31 | 53.53 | 69.29 | 46.47 | 44.53 | 40.31 | 35.78 |
P/S ratio |
8.22 | 8.13 | 9.15 | 10.30 | 15.43 | 12.95 | 11.17 | 8.61 | 6.85 | 6.87 |
P/FCF ratio |
38.20 | 170.25 | 72.83 | 48.44 | 57.60 | 88.78 | 53.71 | 46.78 | 28.74 | 42.11 |
P/Operating CF |
110.57 | (347.04) | 335.64 | 162.56 | 216.14 | 142.07 | 120.59 | 109.41 | 64.66 | 101.17 |
P/B ratio |
4.82 | 4.40 | 6.82 | 7.92 | 13.84 | 12.42 | 11.71 | 10.20 | 7.96 | 7.77 |
Price to Tangible BV |
6.70 | 6.22 | 8.86 | 10.55 | 18.59 | 18.50 | 18.37 | 19.02 | 17.28 | 11.38 |
EV/Sales |
7.62 | 7.52 | 8.95 | 10.17 | 15.27 | 12.77 | 10.97 | 8.67 | 6.76 | 6.71 |
EV/EBITDA |
32.55 | 26.66 | 30.84 | 27.70 | 43.78 | 55.75 | 38.58 | 39.10 | 19.83 | 23.27 |
EV/Operating CF |
28.99 | 75.41 | 50.05 | 37.25 | 46.13 | 53.13 | 40.31 | 34.84 | 23.21 | 28.25 |
EV/FCF |
35.44 | 157.34 | 71.23 | 47.81 | 56.99 | 87.56 | 52.72 | 47.13 | 28.37 | 41.18 |
Quick Ratio |
2.83 | 3.12 | 2.06 | 1.87 | 2.07 | 2.24 | 2.34 | 1.70 | 1.28 | 3.17 |
Current Ratio |
3.72 | 4.18 | 3.38 | 3.03 | 3.08 | 3.46 | 3.31 | 2.61 | 1.80 | 4.21 |
Net Debt/EBITDA |
(2.55) | (2.20) | (0.71) | (0.36) | (0.46) | (0.78) | (0.73) | (0.44) | (0.26) | (0.52) |
Debt/Assets |
4.37% | 4.58% | 6.38% | 7.50% | 7.31% | 8.59% | 9.56% | 11.15% | 18.29% | 18.23% |
Debt/Equity |
0.06 | 0.06 | 0.09 | 0.11 | 0.11 | 0.14 | 0.15 | 0.19 | 0.35 | 0.31 |
Asset Turnover |
0.45 | 0.49 | 0.57 | 0.53 | 0.66 | 0.64 | 0.74 | 0.68 | 0.68 | 0.69 |
Operating CF/Net income |
1.49 | 0.13 | 0.64 | 0.80 | 1.15 | 1.28 | 1.13 | 1.28 | 1.71 | 1.24 |
Capex/Depreciation |
(1.66) | (1.82) | (1.84) | (1.90) | (2.45) | (3.80) | (3.12) | (3.12) | (2.14) | (3.05) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 10.52% | 49.75% | 22.39% | 26.14% | 28.88% | 18.88% | 28.73% | 23.69% | 20.94% | 22.24% | |
| 8.03% | 37.24% | 15.89% | 18.12% | 19.10% | 12.00% | 17.73% | 13.14% | 11.47% | 13.30% | |
ROIC |
11.78% | 12.89% | 14.39% | 17.96% | 21.17% | 14.79% | 22.04% | 16.83% | 25.64% | 22.57% |
Return on Tangible Assets |
15.93% | 64.56% | 31.65% | 41.06% | 40.68% | 22.92% | 33.32% | 31.71% | 32.26% | 24.90% |
Average Days of Receivables |
54.87 | 48.81 | 60.33 | 57.16 | 46.38 | 50.16 | 50.29 | 52.68 | 50.93 | 51.06 |
Research and Development Expense of Revenue |
17.79% | 19.36% | 19.22% | 18.90% | 17.26% | 17.34% | 17.31% | 16.71% | 16.09% | 14.92% |
Selling, General and Administrative Expense of Revenue |
34.37% | 32.89% | 31.59% | 30.41% | 28.55% | 28.01% | 28.57% | 29.24% | 28.84% | 30.53% |
Intangible Assets out of Total Assets |
0.21 | 0.23 | 0.17 | 0.17 | 0.18 | 0.21 | 0.23 | 0.27 | 0.28 | 0.18 |
Share Based Compensation of Revenue |
2.61% | 2.98% | 2.78% | 2.84% | 2.09% | 2.11% | 1.87% | 1.91% | 1.79% | 1.92% |
Graham Net Nets |
0.07 | 0.07 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | (0.01) | 0.02 |
Graham Number |
27.05 | 51.42 | 23.99 | 22.74 | 22.58 | 14.75 | 15.81 | 11.36 | 9.85 | 9.06 |
Earnings Yield |
2.16% | 9.43% | 3.06% | 3.30% | 1.87% | 1.44% | 2.15% | 2.25% | 2.48% | 2.80% |
Free Cash Flow Yield |
2.62% | 0.59% | 1.37% | 2.06% | 1.74% | 1.13% | 1.86% | 2.14% | 3.48% | 2.37% |
Revenue per Share |
10.38 | 9.10 | 8.26 | 7.21 | 8.39 | 7.05 | 6.96 | 5.93 | 5.43 | 4.64 |
Operating CF per Share |
2.73 | 0.91 | 1.48 | 1.97 | 2.78 | 1.69 | 1.89 | 1.48 | 1.58 | 1.10 |
Capex per Share |
(0.44) | (0.47) | (0.44) | (0.43) | (0.53) | (0.65) | (0.45) | (0.39) | (0.28) | (0.34) |
Free Cash Flow per Share |
2.28 | 0.43 | 1.04 | 1.54 | 2.25 | 1.04 | 1.45 | 1.09 | 1.30 | 0.76 |
Cash per Share |
7.23 | 6.65 | 2.69 | 1.96 | 2.35 | 2.25 | 2.43 | 1.52 | 2.11 | 1.99 |
Shareholders Equity per Share |
17.68 | 16.84 | 11.08 | 9.38 | 9.36 | 7.35 | 6.64 | 5.00 | 4.67 | 4.10 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
17.68 | 16.84 | 11.08 | 9.38 | 9.36 | 7.35 | 6.64 | 5.00 | 4.67 | 4.10 |
Free Cash Flow |
1,335.00 | 259.90 | 629.50 | 953.40 | 1,402.30 | 647.00 | 904.50 | 685.00 | 825.20 | 487.00 |
Working Capital |
4,925.20 | 4,780.20 | 2,840.30 | 2,073.40 | 2,148.40 | 2,197.10 | 2,081.60 | 1,410.30 | 1,129.20 | 1,707.50 |
Capital Expenditures |
(260.20) | (282.40) | (266.30) | (264.80) | (329.80) | (407.30) | (278.40) | (241.70) | (175.50) | (217.40) |
Net Current Asset Value |
3,379.30 | 3,293.00 | 1,391.90 | 610.00 | 514.00 | 428.20 | 644.20 | 103.60 | (161.00) | 349.00 |
EV/EBIT |
36.58 | 29.66 | 34.26 | 30.29 | 47.27 | 62.41 | 41.58 | 43.15 | 21.32 | 25.39 |
Capex to Sales |
0.04 | 0.05 | 0.05 | 0.06 | 0.06 | 0.09 | 0.06 | 0.06 | 0.05 | 0.07 |
Net Profit Margin |
17.69% | 76.75% | 27.99% | 34.09% | 28.73% | 18.77% | 24.08% | 19.40% | 16.99% | 19.22% |
Price to Operating Income |
39.44 | 32.09 | 35.03 | 30.68 | 47.77 | 63.28 | 42.37 | 42.83 | 21.60 | 25.96 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 | 0.09 | 0.12 | 0.12 |
Cash ROIC |
(1.43%) | (7.81%) | (7.77%) | (5.42%) | 2.34% | (5.17%) | 1.95% | 1.26% | 6.02% | 2.64% |
Accounts Receivable Turnover |
7.40 | 6.99 | 6.56 | 6.55 | 8.26 | 7.30 | 7.65 | 7.32 | 7.69 | 7.54 |
Accounts Payable Turnover |
6.28 | 5.82 | 5.04 | 3.56 | 6.23 | 5.73 | 7.09 | 7.50 | 8.19 | 9.91 |
Inventory Turnover |
1.21 | 1.12 | 1.10 | 0.90 | 1.63 | 1.50 | 1.79 | 1.62 | 1.84 | 2.17 |
Average Days of Payables |
62.24 | 64.48 | 69.61 | 101.83 | 59.77 | 66.37 | 59.09 | 52.07 | 48.62 | 44.45 |
Days of Inventory on Hand |
308.10 | 354.94 | 337.06 | 441.56 | 212.38 | 271.00 | 209.91 | 235.85 | 231.39 | 181.54 |
Average Receivables |
819.75 | 777.75 | 763.60 | 682.00 | 633.85 | 600.95 | 568.20 | 508.30 | 446.95 | 393.20 |
Average Payables |
212.45 | 192.00 | 194.25 | 203.20 | 200.50 | 188.45 | 157.20 | 125.30 | 106.85 | 80.50 |
Average Inventory |
1,106.45 | 995.10 | 889.50 | 801.10 | 764.50 | 721.60 | 623.95 | 580.95 | 475.75 | 368.25 |
Average Assets |
13,376.25 | 11,209.25 | 8,827.85 | 8,397.55 | 7,869.85 | 6,862.60 | 5,905.90 | 5,495.05 | 5,088.20 | 4,283.15 |
Average Common Equity |
10,200.25 | 8,391.15 | 6,263.05 | 5,821.30 | 5,205.10 | 4,361.30 | 3,644.35 | 3,048.30 | 2,787.60 | 2,561.05 |
Columns are period end dates